Molecular Marker Discovery and Evaluation: EGF rs1897990 and rs1524106 Variants in a China Lung Adenocarcinoma Young Population

ABSTRACT Objective The objective of this study is to investigate the genetic susceptibility and risk factors of EGF gene rs1897990 and rs1524106 in lung adenocarcinoma young patients aged ≤ 45 years. Methods A case–control study was conducted. DNA was extracted and identified from 88 samples from ca...

Full description

Saved in:
Bibliographic Details
Main Authors: Huiwen Pan, Xiangyang Wang, Lijie Zheng, Jinye Wang, Guowen Ding, Jingfeng Zhu, Zhijie Fang
Format: Article
Language:English
Published: Wiley 2025-07-01
Series:The Clinical Respiratory Journal
Subjects:
Online Access:https://doi.org/10.1111/crj.70113
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:ABSTRACT Objective The objective of this study is to investigate the genetic susceptibility and risk factors of EGF gene rs1897990 and rs1524106 in lung adenocarcinoma young patients aged ≤ 45 years. Methods A case–control study was conducted. DNA was extracted and identified from 88 samples from case and control groups by single‐nucleotide polymorphism assay. PCR amplification was performed by TaqMan probe method, and the factors of smoking, drinking, sex, and age were also included. To investigate the clinical factors and genotyping differences between case and control groups. Results Smoking was an influential factor in young lung adenocarcinoma patients. The mutation frequency of EGF gene rs1897990 CT heterozygous mutant was different between the two groups (p = 0.021). The T alleles of EGF rs1897990 and rs1524106 were significantly different between the two groups (p = 0.034 and p = 0.023). Conclusions The young lung adenocarcinoma population (≤ 45 years old) is susceptible to EGF rs1897990 and rs1524106 variants, with smoking being another risk factor. Additionally, smoking may enhance the risk of EGF rs1897990 and rs1524106 variants threatening the development of lung adenocarcinoma.
ISSN:1752-6981
1752-699X